The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
U.S. Hospitalizations for Pneumonia after a Decade of Pneumococcal Vaccination
Open accessAbstract
BACKGROUND: The introduction of 7-valent pneumococcal conjugate vaccine (PCV7) into the U.S. childhood immunization schedule in 2000 has substantially reduced the incidence of vaccine-serotype invasive pneumococcal disease in young children and in unvaccinated older children and adults. By 2004, hospitalizations associated with pneumonia from any cause had also declined markedly among young children. Because of concerns about increases in disease caused by nonvaccine serotypes, we wanted to determine whether the reduction in pneumonia-related hospitalizations among young children had been sustained through 2009 and whether such hospitalizations in older age groups had also declined. METHODS: We estimated annual rates of hospitalization for pneumonia from any cause using the Nationwide Inpatient Sample database. The reason for hospitalization was classified as pneumonia if pneumonia was the first listed diagnosis or if it was listed after a first diagnosis of sepsis, meningitis, or empyema. Average annual rates of pneumonia-related hospitalizations from 1997 through 1999 (before the introduction of PCV7) and from 2007 through 2009 (well after its introduction) were used to estimate annual declines in hospitalizations due to pneumonia. RESULTS: The annual rate of hospitalization for pneumonia among children younger than 2 years of age declined by 551.1 per 100,000 children (95% confidence interval [CI], 445.1 to 657.1), which translates to 47,000 fewer hospitalizations annually than expected on the basis of the rates before PCV7 was introduced. The rate for adults 85 years of age or older declined by 1300.8 per 100,000 (95% CI, 984.0 to 1617.6), which translates to 73,000 fewer hospitalizations annually. For the three age groups of 18 to 39 years, 65 to 74 years, and 75 to 84 years, the annual rate of hospitalization for pneumonia declined by 8.4 per 100,000 (95% CI, 0.6 to 16.2), 85.3 per 100,000 (95% CI, 7.0 to 163.6), and 359.8 per 100,000 (95% CI, 199.6 to 520.0), respectively. Overall, we estimated an age-adjusted annual reduction of 54.8 per 100,000 (95% CI, 41.0 to 68.5), or 168,000 fewer hospitalizations for pneumonia annually. CONCLUSIONS: Declines in hospitalizations for childhood pneumonia were sustained during the decade after the introduction of PCV7. Substantial reductions in hospitalizations for pneumonia among adults were also observed. (Funded by the Centers for Disease Control and Prevention.).
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Whitney, C. G., Farley, M. M., Hadler, J., Harrison, L. H., Bennett, N. M., Lynfield, R., Reingold, A., Cieslak, P. R., Pilishvili, T., Jackson, D., et al. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa022823 · Cited by 2,228
Self-citationFiore, A. E., Uyeki, T. M., Broder, K. R., Finelli, L., Euler, G. L., Singleton, J. A., Iskander, J. K., Wortley, P. M., Shay, D. K., Bresee, J., et al. (2009) · PubMed · Cited by 1,965
Sustained Reductions in Invasive Pneumococcal Disease in the Era of Conjugate Vaccine
Pilishvili, T., Lexau, C., Farley, M. M., Hadler, J., Harrison, L. H., Bennett, N. M., Reingold, A., Thomas, A., Schaffner, W., Craig, A. S., et al. (2010) · The Journal of Infectious Diseases · doi:10.1086/648593 · Cited by 1,311
Self-citationSerotype replacement in disease after pneumococcal vaccination
Weinberger, D. M., Malley, R., & Lipsitch, M. (2011) · The Lancet · doi:10.1016/s0140-6736(10)62225-8 · Cited by 1,020
(2013) · American Journal of Transplantation · doi:10.1111/ajt.12073 · Cited by 687
Grijalva, C. G., Nuorti, J. P., Arbogast, P. G., Martin, S. W., Edwards, K. M., & Griffin, M. R. (2007) · The Lancet · doi:10.1016/s0140-6736(07)60564-9 · Cited by 667
Self-citationSingleton, R. J., Hennessy, T. W., Bulkow, L. R., Hammitt, L. L., Zulz, T., Hurlburt, D. A., Butler, J. C., Rudolph, K., & Parkinson, A. (2007) · JAMA · doi:10.1001/jama.297.16.1784 · Cited by 615
Antibiotic Prescription Rates for Acute Respiratory Tract Infections in US Ambulatory Settings
Grijalva, C. G. (2009) · JAMA · doi:10.1001/jama.2009.1163 · Cited by 513
Self-citationFry, A. M. (2005) · JAMA · doi:10.1001/jama.294.21.2712 · Cited by 425
A Trial of a 7-Valent Pneumococcal Conjugate Vaccine in HIV-Infected Adults
French, N., Gordon, S. B., Mwalukomo, T., White, S. A., Mwafulirwa, G., Longwe, H., Mwaiponya, M., Zijlstra, E. E., Molyneux, M. E., & Gilks, C. F. (2010) · New England Journal of Medicine · doi:10.1056/nejmoa0903029 · Cited by 352
Cited by
Community-Acquired Pneumonia Requiring Hospitalization among U.S. Adults
Jain, S., Self, W. H., Wunderink, R. G., Fakhran, S., Balk, R., Bramley, A. M., Reed, C., Grijalva, C. G., Anderson, E. J., Courtney, D. M., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1500245 · Cited by 2,323
Self-citationCommunity-Acquired Pneumonia Requiring Hospitalization among U.S. Children
Jain, S., Williams, D. J., Arnold, S. R., Ampofo, K., Bramley, A. M., Reed, C., Stockmann, C., Anderson, E. J., Grijalva, C. G., Self, W. H., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1405870 · Cited by 1,804
Self-citationRespiratory risks from household air pollution in low and middle income countries
Gordon, S. B., Bruce, N. G., Grigg, J., Hibberd, P. L., Kurmi, O. P., Lam, K.-B. H., Mortimer, K., Asante, K. P., Balakrishnan, K., Balmes, J., et al. (2014) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(14)70168-7 · Cited by 953
Moore, M. R., Link-Gelles, R., Schaffner, W., Lynfield, R., Lexau, C., Bennett, N. M., Petit, S., Zansky, S. M., Harrison, L. H., Reingold, A., et al. (2015) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(14)71081-3 · Cited by 733
Self-citationMusher, D. M., & Thorner, A. R. (2014) · New England Journal of Medicine · doi:10.1056/nejmra1312885 · Cited by 626
Adults Hospitalized With Pneumonia in the United States: Incidence, Epidemiology, and Mortality
Ramirez, J. A., Wiemken, T. L., Peyrani, P., Arnold, F. W., Kelley, R., Mattingly, W. A., Nakamatsu, R., Pena, S., Guinn, B. E., Furmanek, S. P., et al. (2017) · Clinical Infectious Diseases · doi:10.1093/cid/cix647 · Cited by 624
Human Vaccines & Immunotherapeutics: News
Riedmann, E. M. (2013) · Human Vaccines & Immunotherapeutics · doi:10.4161/hv.26189 · Cited by 462
Pneumococcal infection in adults: burden of disease
Drijkoningen, J. J. C., & Rohde, G. G. U. (2014) · Clinical Microbiology and Infection · doi:10.1111/1469-0691.12461 · Cited by 384
The global burden of respiratory disease-Impact on child health
Zar, H. J., & Ferkol, T. W. (2014) · Pediatric Pulmonology · doi:10.1002/ppul.23030 · Cited by 347
Claessens, Y.-E., Debray, M.-P., Tubach, F., Brun, A.-L., Rammaert, B., Hausfater, P., Naccache, J.-M., Ray, P., Choquet, C., Carette, M.-F., et al. (2015) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201501-0017oc · Cited by 322
Integrative Physiology of Pneumonia
Quinton, L. J., Walkey, A. J., & Mizgerd, J. P. (2018) · Physiological Reviews · doi:10.1152/physrev.00032.2017 · Cited by 295
Rates of Pneumococcal Disease in Adults With Chronic Medical Conditions
Shea, K. M., Edelsberg, J., Weycker, D., Farkouh, R. A., Strutton, D. R., & Pelton, S. I. (2014) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofu024 · Cited by 276
Daniels, C. C., Rogers, P. D., & Shelton, C. M. (2016) · The Journal of Pediatric Pharmacology and Therapeutics · doi:10.5863/1551-6776-21.1.27 · Cited by 273
Wunderink, R. G., & Waterer, G. W. (2014) · New England Journal of Medicine · doi:10.1056/nejmcp1214869 · Cited by 267
Zaidi, S. R., & Blakey, J. D. (2019) · Respirology · doi:10.1111/resp.13528 · Cited by 56
Metadata
- Authors
- Griffin, M. R., Zhu, Y., Moore, M. R., Whitney, C. G., & Grijalva, C. G.
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2013-07-11
- Volume
- 369
- Issue
- 2
- Pages
- 155-163
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2097129414
- Cited by
- 506
- References
- 30
- FWCI
- 48.21
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.